Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Visconti

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Endocrine-Related Cancer|August 16, 2017
Fighting tubulin-targeting anticancer drug toxicity and resistanceRoberta Visconti, Domenico Grieco
Current Opinion in Drug Discovery & Development|April 1, 2009
New insights on oxidative stress in cancerRoberta Visconti, Domenico Grieco
Methods in Molecular Biology (Clifton, N.J.)|March 4, 2008
Functional cloning of genes regulating apoptosis in neuronal cellsRoberta Visconti, Luciano D'Adamio
Cell Cycle (Georgetown, Tex.)|January 19, 2010
Requirement for proteolysis in spindle assembly checkpoint silencingRoberta Visconti, Luca Palazzo, Domenico Grieco
Molecular Cancer|February 20, 2018
The rationale for druggability of CCDC6-tyrosine kinase fusions in lung cancerAniello Cerrato, Roberta Visconti, Angela Celetti
Cell Death & Disease|May 14, 2020
Exploiting immune-dependent effects of microtubule-targeting agents to improve efficacy and tolerability of cancer treatmentAngela Flavia Serpico, Roberta Visconti, Domenico Grieco
Molecular & Cellular Oncology|June 17, 2016
Sustaining the spindle assembly checkpoint to improve cancer therapyRoberta Visconti, Rosa Della Monica, Domenico Grieco
Journal of Experimental & Clinical Cancer Research : CR|September 28, 2016
Cell cycle checkpoint in cancer: a therapeutically targetable double-edged swordRoberta Visconti, Rosa Della Monica, Domenico Grieco
The Journal of Clinical Investigation|May 22, 2002
Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathwaysFabio Candotti, Luigi Notarangelo, Roberta Visconti, et al.
International Journal of Molecular Sciences|June 28, 2017
The between Now and Then of Lung Cancer Chemotherapy and ImmunotherapyRoberta Visconti, Francesco Morra, Gianluca Guggino, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Endocrine-Related Cancer|August 16, 2017
Fighting tubulin-targeting anticancer drug toxicity and resistanceRoberta Visconti, Domenico Grieco
Current Opinion in Drug Discovery & Development|April 1, 2009
New insights on oxidative stress in cancerRoberta Visconti, Domenico Grieco
Methods in Molecular Biology (Clifton, N.J.)|March 4, 2008
Functional cloning of genes regulating apoptosis in neuronal cellsRoberta Visconti, Luciano D'Adamio
Cell Cycle (Georgetown, Tex.)|January 19, 2010
Requirement for proteolysis in spindle assembly checkpoint silencingRoberta Visconti, Luca Palazzo, Domenico Grieco
Molecular Cancer|February 20, 2018
The rationale for druggability of CCDC6-tyrosine kinase fusions in lung cancerAniello Cerrato, Roberta Visconti, Angela Celetti
Cell Death & Disease|May 14, 2020
Exploiting immune-dependent effects of microtubule-targeting agents to improve efficacy and tolerability of cancer treatmentAngela Flavia Serpico, Roberta Visconti, Domenico Grieco
Molecular & Cellular Oncology|June 17, 2016
Sustaining the spindle assembly checkpoint to improve cancer therapyRoberta Visconti, Rosa Della Monica, Domenico Grieco
Journal of Experimental & Clinical Cancer Research : CR|September 28, 2016
Cell cycle checkpoint in cancer: a therapeutically targetable double-edged swordRoberta Visconti, Rosa Della Monica, Domenico Grieco
The Journal of Clinical Investigation|May 22, 2002
Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathwaysFabio Candotti, Luigi Notarangelo, Roberta Visconti, et al.
International Journal of Molecular Sciences|June 28, 2017
The between Now and Then of Lung Cancer Chemotherapy and ImmunotherapyRoberta Visconti, Francesco Morra, Gianluca Guggino, et al.
Pageof 5